[Present conditions and the prospects for biomarker measurement in breast cancer].
Kawamoto
Hisanori
H
Department of Breast and Endocrine Surgery, St. Marianna University School of Medicine.
Fukuda
Mamoru
M
D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis; D051017:Apoptosis Regulatory Proteins; D019313:BRCA1 Protein / Q000235:genetics; D024682:BRCA2 Protein / Q000235:genetics; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000517:prevention & control / Q000628:therapy; D002272:Carcinoembryonic Antigen / Q000032:analysis; D005260:Female; D006801:Humans; D018396:Mucin-1 / Q000032:analysis; D009154:Mutation; D011379:Prognosis; D019396:Tissue Polypeptide Antigen / Q000032:analysis
D015295:Antigens, Tumor-Associated, Carbohydrate; D051017:Apoptosis Regulatory Proteins; C118024:BLID protein, human; D019313:BRCA1 Protein; C492913:BRCA1 protein, human; D024682:BRCA2 Protein; C551750:BRCA2 protein, human; D014408:Biomarkers, Tumor; C090797:CA 27-29 antigen; D002272:Carcinoembryonic Antigen; D018396:Mucin-1; C056315:ST 439 antigen, human; D019396:Tissue Polypeptide Antigen